Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1990-05-14
1995-10-17
Lacey, David L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242791, 435 697, 5303873, 5303917, A61K 39104, C07K 300, C07K 1528, C12P 2108
Patent
active
054588782
ABSTRACT:
A target-specific, cytotoxic, recombinant Pseudomonas exotoxin is described. Such toxins are made by inserting specific recognition molecules at specific cloning sites in at least domain III near the carboxyl terminus of the PE molecule. Various modifications of the carboxyl terminus of the PE molecule to increase cytotoxicity are set forth. Multifunctional, recombinant, cytotoxic fusion proteins containing at least two different recognition molecules are provided for killing cells expressing receptors to which the recognition molecules bind with specificity. Methods for producing novel recombinant PE molecules with specific properties are described.
REFERENCES:
patent: 4545985 (1985-10-01), Pastan et al.
patent: 4892827 (1990-01-01), Pastan et al.
Siegall et al., Proc. Nat'l. Acad. Sci. USA, vol. 85, Dec. 1988, pp. 9738-9742.
Chaudhary et al., Nature, 1988.
Hwang et al., Cell, Jan., 1987.
Chaudhary et al., Proc. Nat'l Acad. Sci USA Genetics, vol. 84, Jul. 1987 pp. 4538-4542.
Siegall et al; J. of Biological Chemistry, vol. 264, No. 24, Aug., 1989, pp. 14256-14261.
Chaudhary et al., Proc. Nat'l. Acad Sci USA, vol. 84, Jan. 1990, pp. 308-312.
Munro et al, Cell, vol. 48, Mar., 1987, pp. 899-907.
Chow et al; J. of Biol. Chem., vol. 264, No. 31, Nov., 1989, pp. 18818-18823.
Waldmann, J. of Nat'l Cancer Inst., vol. 81, No. 12, Jun., 1989, pp. 914-923.
Lorberboum-Galski, Proc. Nat'l. Acad. Sci USA, vol. 86, Feb., 1989, pp. 1008-1012.
Lorberboum-Galski, J. of Biol. Chem., vol. 263, No. 35, Dec., 1988, pp. 18650-18656.
Lorberboum-Galski, Proc. Nat'l. Acad. Sci USA, vol. 85, Mar., 1988, pp. 1922-1926.
Bailon et al., Biotechnology, Nov., 1988, pp. 1326-1329.
Ogata et al., J. of Immunology, vol. 141, No. 12, Dec., 1988. 4224-4228.
Case et al., Proc. Nat'l Acad. Sci USA, vol. 86, Jan., 1989, pp. 287-291.
Chaudhary Vijay K.
FitzGerald David
Pastan Ira
Lacey David L.
Nisbet T. Michael
The United States of America as represented by the Secretary of
LandOfFree
P. exotoxin fusio proteins have COOHG220101al alterations which does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P. exotoxin fusio proteins have COOHG220101al alterations which , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P. exotoxin fusio proteins have COOHG220101al alterations which will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-595206